EN DE
STOCK COMPARISON

Garden Stage Limited Ordinary Shares vs Morgan Stanley: Fair Value & Quality

Both stocks run through our valuation models. Here is how Garden Stage Limited Ordinary Shares (GSIW) and Morgan Stanley (MS) compare, as of Aug 26, 2026.

As of Aug 26, 2026, Fair Value Calculator sees Morgan Stanley as the less overvalued of the two: Garden Stage Limited Ordinary Shares trades at $15.09 versus a fair value of $2.75 (-82%), while Morgan Stanley trades at $217 versus $139 (-36%).
Garden Stage Limited Ordinary Shares
GSIW · USD · Financials
-82%
upside to fair value
overvalued
Price$15.09
Fair Value$2.75
Quality33/100
Morgan Stanley
MS · USD · Financials
-36%
upside to fair value
overvalued
Price$217
Fair Value$139
Quality67/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Garden Stage Limited Ordinary SharesMorgan Stanley
Valuation
P/E (TTM)20.1×
6.11×P/S (TTM)4.79×
7.38×P/B3.14×
EV/EBITDA22.1×
PEG2.64×
Dividend yield1.8%
Dividend per share$4.00
Profitability
-93%Net margin25%
-192%Operating margin41%
-56%Return on equity16%
-31%Return on assets1%
Growth
415%Revenue growth (YoY)16%
163.2%Avg. growth/yr (3Y)22.5%
Avg. growth/yr (5Y)18.3%
Balance & size
Debt / equity3.13×
$49MMarket cap$351B
expensiveGrowth qualitymixed

Morgan Stanley leads: 2 to 6 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Garden Stage Limited Ordinary Sharesof which business quality 33 · market factors 8 Morgan Stanleyof which business quality 62 · market factors 72
ProfitabilityMargins and returns on capital today
4
31
Quality GrowthAre margins and returns improving?
91
56
CashflowEarnings quality: real cash, not paper profit
0
100
Fin. StrengthBalance sheet, leverage, solvency risk
57
26
InvestmentDisciplined investing over empire-building
30
82
Low VolatilityCalm price path (market factor)
0
58
MomentumPrice trend over the last 3–12 months (market factor)
16
73
52W MomentumDistance to the 52-week high (market factor)
3
87
Net IssuanceBuybacks instead of dilution
38
96

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Garden Stage Limited Ordinary Shares

Asset-Based$3.18

1 of 1 models see the stock below the current price.

Morgan Stanley

DCF Models$130
Earnings-Based$214
Dividend Discount$79.85
Multiples$119
Asset-Based$47.42
Growth DCF$332
Economic Profit$95.82

11 of 13 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Garden Stage Limited Ordinary Shares
Bear $1.82Fair Value $2.75Bull $3.44
$15.09 = current price (white tick)
Morgan Stanley
Bear $76.96Fair Value $139Bull $228
$217 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Garden Stage Limited Ordinary Shares · Financials

Quality score33 · bottom 25%
Fair value upside-82% · bottom 25%

Morgan Stanley · Financials

Quality score67 · Top 25%
Fair value upside-36% · below median

Bottom line

As of Aug 26, 2026, Fair Value Calculator sees Morgan Stanley as the less overvalued of the two: Garden Stage Limited Ordinary Shares trades at $15.09 versus a fair value of $2.75 (-82%), while Morgan Stanley trades at $217 versus $139 (-36%).

Morgan Stanley has the higher quality score (67/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.